GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Inventories, Raw Materials & Components

Celadon Pharmaceuticals (LSE:CEL) Inventories, Raw Materials & Components : €0.03 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals Inventories, Raw Materials & Components?

Celadon Pharmaceuticals's inventories, raw materials & components for the quarter that ended in Dec. 2023 was €0.03 Mil.

Celadon Pharmaceuticals's quarterly raw materials declined from Dec. 2022 (€0.02 Mil) to Jun. 2023 (€0.00 Mil) but then increased from Jun. 2023 (€0.00 Mil) to Dec. 2023 (€0.03 Mil).

Celadon Pharmaceuticals's annual raw materials increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.02 Mil) and increased from Dec. 2022 (€0.02 Mil) to Dec. 2023 (€0.03 Mil).


Celadon Pharmaceuticals Inventories, Raw Materials & Components Historical Data

The historical data trend for Celadon Pharmaceuticals's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals Inventories, Raw Materials & Components Chart

Celadon Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
- - - 0.02 0.03

Celadon Pharmaceuticals Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Inventories, Raw Materials & Components Get a 7-Day Free Trial - - 0.02 - 0.03

Celadon Pharmaceuticals Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Celadon Pharmaceuticals (LSE:CEL) Business Description

Industry
Traded in Other Exchanges
N/A
Address
32-33 Cowcross Street, London, GBR, EC1M 6DF
Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis.

Celadon Pharmaceuticals (LSE:CEL) Headlines

No Headlines